Jeff Garro
Stock Analyst at Stephens & Co.
(1.26)
# 3,281
Out of 5,058 analysts
55
Total ratings
37.84%
Success rate
-10.28%
Average return
Main Sectors:
Stocks Rated by Jeff Garro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OPRX OptimizeRx | Maintains: Equal-Weight | $20 → $17 | $14.26 | +19.21% | 4 | Nov 17, 2025 | |
| PRVA Privia Health Group | Reiterates: Overweight | $32 | $22.55 | +41.93% | 5 | Sep 24, 2025 | |
| EVH Evolent Health | Reiterates: Equal-Weight | $9 | $3.54 | +154.24% | 6 | Sep 24, 2025 | |
| PHR Phreesia | Reiterates: Overweight | $32 | $19.19 | +66.75% | 9 | Sep 3, 2025 | |
| SLP Simulations Plus | Maintains: Overweight | $28 → $20 | $16.32 | +22.55% | 2 | Jul 15, 2025 | |
| TBRG TruBridge | Reiterates: Equal-Weight | $28 | $20.61 | +35.86% | 3 | Apr 10, 2025 | |
| VEEV Veeva Systems | Reiterates: Overweight | $280 | $273.00 | +2.56% | 2 | Mar 6, 2025 | |
| HCAT Health Catalyst | Maintains: Equal-Weight | $7 → $5 | $2.11 | +136.97% | 4 | Mar 6, 2025 | |
| CERT Certara | Reiterates: Overweight | $17 | $8.29 | +105.07% | 5 | Feb 27, 2025 | |
| DH Definitive Healthcare | Initiates: Equal-Weight | $5 | $2.59 | +93.42% | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $55 | $48.00 | +14.58% | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $250 | $217.48 | +14.95% | 2 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $20.81 | -18.31% | 1 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $28 | $7.05 | +297.16% | 2 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $20 | $16.33 | +22.47% | 3 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $5 → $3.9 | $5.01 | -22.16% | 2 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4 → $3 | $1.39 | +115.83% | 3 | May 6, 2022 |
OptimizeRx
Nov 17, 2025
Maintains: Equal-Weight
Price Target: $20 → $17
Current: $14.26
Upside: +19.21%
Privia Health Group
Sep 24, 2025
Reiterates: Overweight
Price Target: $32
Current: $22.55
Upside: +41.93%
Evolent Health
Sep 24, 2025
Reiterates: Equal-Weight
Price Target: $9
Current: $3.54
Upside: +154.24%
Phreesia
Sep 3, 2025
Reiterates: Overweight
Price Target: $32
Current: $19.19
Upside: +66.75%
Simulations Plus
Jul 15, 2025
Maintains: Overweight
Price Target: $28 → $20
Current: $16.32
Upside: +22.55%
TruBridge
Apr 10, 2025
Reiterates: Equal-Weight
Price Target: $28
Current: $20.61
Upside: +35.86%
Veeva Systems
Mar 6, 2025
Reiterates: Overweight
Price Target: $280
Current: $273.00
Upside: +2.56%
Health Catalyst
Mar 6, 2025
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $2.11
Upside: +136.97%
Certara
Feb 27, 2025
Reiterates: Overweight
Price Target: $17
Current: $8.29
Upside: +105.07%
Definitive Healthcare
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $5
Current: $2.59
Upside: +93.42%
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $55
Current: $48.00
Upside: +14.58%
Dec 20, 2024
Initiates: Overweight
Price Target: $250
Current: $217.48
Upside: +14.95%
Dec 9, 2024
Initiates: Buy
Price Target: $17
Current: $20.81
Upside: -18.31%
Jul 26, 2023
Reiterates: Equal-Weight
Price Target: $28
Current: $7.05
Upside: +297.16%
Aug 5, 2022
Maintains: Overweight
Price Target: $15 → $20
Current: $16.33
Upside: +22.47%
May 11, 2022
Maintains: Underweight
Price Target: $5 → $3.9
Current: $5.01
Upside: -22.16%
May 6, 2022
Maintains: Neutral
Price Target: $4 → $3
Current: $1.39
Upside: +115.83%